A Single Arm, Open-label Study of Early Improvement of Anemia and Fatigue During Treatment With Tocilizumab (TCZ) in Combination With DMARDs, in Adult Patients With Moderate to Severe Active Rheumatoid Arthritis.
Phase of Trial: Phase III
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Disease-modifying antirheumatics (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 08 Aug 2012 Actual patient number changed from 78 to 105 as reported by ClinicalTrials.gov record.
- 08 Aug 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.